C. Beata, . E. Beaumont-graff, V. Coll, !. Corde, J. Marion et al.,

J. Tauzin, Effect of alpha-casozepine (Zylkene) on anxiet y in cats. journal of Veterinary Behavior, Clinical Applications and Research, vol.2, issue.2, pp.40-46, 2007.

C. Beata, E. Beaumont-graff, C. Diaz, M. Marion, N. Massai et al., Effects of alpha-casozepine (Zylkene) versus selegiline hydrochloride (Selgian, Anipryl) on anxiety disorders in dogs. journal of Veterinary Behavior, Clinical Applicatio ns and Research, vol.2, issue.5, pp.175-183, 2007.

C. H. Beek and H. C. Fibiger, Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: Wit h and w ithout d iazepam pretreatment. The j ournal of Neuroscience : The Official journal of the Society for Neuroscience, vol.15, pp.709-720, 1995.

M. Bourin and M. Hascoët, The mou se lightfdark box test, European j ournal of Pharmacology, vol.463, issue.1 -3, pp.1274-1277, 2003.

C. Cakir-kiefer, Y. Le-roux, F. Balandras, M. Trabalon, A. Da1y et al., ln vit ro digestibility of 1)(-casozepine, a benzodiazepine-like peptide from bovine casein. and biological activity of its main proteolytic fragment. journal of Agriculrural and Food Chemistry, vol.59, pp.4464-4472, 2011.

. G. Calhoon and K. M. Tye, Resolving t he neural circuits of anxiety, Nature Neuroscience, vol.18, issue.5, pp.1394-1404

L. Chung, A brief introduction to the transduction of neural activity into fos signal, Development & Reproduction, vol.79, issue.5, pp.61-67

J. N. Crawley and F. K. Goodwin, Preliminary report of a simple animal behavior madel for the anxiolytic effects of benzodiazepines, Biochemistry, and Behavior, vol.13, issue.2, pp.167-170, 1980.

. M. De-medeiros,

C. Reis and .. L. ,

. L. &-eugênio-mello, Stress-induced c-Fos expression is differentially modulated by dexamethasone, diazepam and imipramine. Neuropsyclwpharmacology : Official Publication of the American Co/lege of Neuropsy clwpharmacology, vol.30, pp.1246-1247, 2005.

, Dela Peiïa, 1. J, vol.1

H. J. Kim, . J. De-la-peiïa, M. Kim, C. ]. Botanas, and K. Y. Vou,

J. H. Cheong, A tryptic hydrolysate from bovine milk as1-casein enhances pentobarbital-induced sleep in mice via t he GABAA receptor, Behavioural Brain Research, vol.313, issue.6, pp.184-190

G. E. Duncan, D. J. Knapp, and G. R. Breese, Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety, Brain Research, vol.773, issue.1-2, pp.79-91, 1996.

J. M. Fritschy and H. Mahler, GABAA-receptor heterogeneity in the adult rat brain: differentiai regional and cellular distribution of seven major subunits, The journal of Comparative Neurology, issue.1, pp.154-194, 1995.

B. Guesdon, M. Messaoudi, C. Lefranc-millot, G. Fromentin, D. .. Tomé et al., A tryptic hydrolysate from bovine milk alpha51-casein improves sleep in rats subjected to chronic mild stress, Peptides, vol.27, issue.6, pp.1476-1482, 2006.

. J. Herman and W. E. Cullinan, Neurocircuitry of stress: Central cont rol of the hypothalamo-pituitary-adrenocortical axis, Trends i11 Neurosciences, vol.20, pp.78-84, 1997.

N. Kanegawa, . C. Suzuki, and K. Ohinata, Dipeptide Tyr-Leu (YL) exhibits anxiolytic-like activity after oral administration via activating serotonin 5-HTlA. dopamine Dl and GABAA receptors in mice, FEBS Lerrers, vol.584, issue.3, pp.599-604, 2010.

J. H. Kim, D. Desor, Y. T. Kim, W. J. Yoon, K. S. Kim et al.,

. Shim, Efficacy of alphas1-casein hydrolysate on stress-related symptoms in women, vol.1, 2007.

, Nutrition, vol.6, issue.4, pp.1780-1782

T. Mizushige,

Y. Sawashi,

A. Yamada,

R. Kanamoto,

K. Ohinata, Characterization of Tyr-Leu-Giy, a novel anxiolytic-like peptide released from bovine cxS-casein. FASEB]oumal: Official Publication of the Federation of American Societies for Experimental Bio/ogy, vol.27, pp.12-225474, 2013.

H. R. Noori and R. Spa-nagel,

A. C. Hansson, Neurocircuitry for mode ling drug effects, Addiction Bio/ogy, vol.17, issue.5, pp.827-864, 2012.

C. Palestrini, M. Minera, S. Cannas, G. Berteselli, E. Scaglia et al., Efficacy of a diet containing caseinate hydrolysate on signs of stress in dogs. journal of Veterinary Behavior, Clinical Applications and Research, vol.5, issue.6, pp.309-317, 2010.

A. E. Panhelainen and E. R. Korpi, Evidence for a raie of inhibition of orexinergic neurons in the anxiolytic and sedative effects of diazepam: Ac-Fos study, Biochemistry, and Behavior, vol.101, issue.1, pp.115-124, 2012.

G. Paxinos and K. B. Franklin, The Mouse Brain in Stereotaxie Coordinates, Second Ed.), 2001.

. S. Pirker and . C. Schwarzer,

A. Wieselthaler, W. .. Sieghart, and G. Sperk, GABA(A) receptors: lmmunocytochemical distribution of 13 subunits in the adult rat brain, Neuroscience, vol.101, issue.4, pp.15-850, 2000.

. R-core-team, R: A language and environmentfor statistical computing. Vien na, Austria: R Foundation for Statistical Computing, 2013.

W. S. Rasband, Image}. Maryland, USA: U. S. National Institutes of Health, Bethesda, 1997.

J. G. Richards and H. Mahler, Benzodiazepine receptors. Neu ropharmacology, vol.23, pp.233-257, 1984.

U. Rudolph and . F. Crcstani,

D. Bcnkc,

. Brünig and . J. Bcnson,

. H. Mbhlcr, , 1999.

, Benzodiazepine actions mediated by specifie gamma-am inobutyric acid(A) receptor subtypes, Nature, vol.401, issue.6755, pp.796-800

O. Salminen and . S. Lahtinen,

L. Ah-tee, Expression of Fos protein in various rat brain areas following acute nicotine and diazepam. Pharmaco/ogy, Biochemistry, and Behavior, vol.4, pp.241-248, 1996.

. J. Schwarz, J. Burguet, O. Rampin, . G. Fromentin, P. Rey et al.,

N. Darcel, Three-dimensional macronutrient-associated Fos expression patterns in the mouse brainstem, PLoS ONE, vol.5, issue.2, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01173379

Z. Su-n and R. J. Cade,

M. J. Fregly,

R. Malcolm-privette, Beta-casomorphin induces Fos-like immunoreactivity in discrete brain regions relevant to schizoprenia and autism, pp.67-83, 1999.

C. C. Udenigwe and R. E. Aluko, Food protein-derived bioactive peptides: Production, processing, and potential health benefits, journal of Food Science, issue.1, p.77, 2012.

N. Vi-alle,

M. Messaoudi,

C. Lefranc-millot,

D. Desor and A. Nejdi,

B. Demagny and H. Schroeder, Ethological comparison of the effects of a bovine alpha slcasein tryptic hydrolysate and diazepam on the behaviour of rats in two models of anxiety, Biochemistry, and Behavior, vol.84, issue.3, pp.517-523, 2006.

H. Y-ou,

J. L. Kozuska,

1. M. Paulsen and S. M. Dunn, Benzodiazepine modulation of the rat GABAA receptor o.4il3y2L subtype expressed in Xenopus oocytes. Neuropl!armaco/ogy, vol.59, pp.527-533, 2010.

A. Adhikari, Distributed circuits underlying anxiety, Front Behav Neurosci, vol.8, p.112, 2014.

P. Alberts, Subtype classification of presynaptic alpha 2-adrenoceptors, Gen Pharmacol, vol.24, pp.1-8, 1993.

, Diagnostic and statistical manual of mental disorders, vol.4, 2000.

, Diagnostic and statistical manual of mental disorders, 2013.

T. P. Angelotti and R. L. Macdonald, Assembly of GABAA receptor subunits: alpha 1 beta 1 and alpha 1 beta 1 gamma 2S subunits produce unique ion channels with dissimilar singlechannel properties, J Neurosci, vol.13, pp.1429-1469, 1993.

. Ansm, Etat des lieux de la consommation des benzodiazépines en France, 2013.

S. V. Argyropoulos, J. J. Sandford, and D. J. Nutt, The psychobiology of anxiolytic drugs -Part 2: Pharmacological treatments of anxiety, Pharmacol Ther, vol.88, pp.213-227, 2000.

H. Ashton, Guidelines for the rational use of benzodiazepines. When and what to use, Drugs, vol.48, pp.25-40, 1994.

J. R. Atack, Subtype-selective GABA(A) receptor modulation yields a novel pharmacological profile: the design and development of TPA023, Adv Pharmacol, vol.57, pp.137-185, 2009.

J. Awapara, A. J. Landua, R. Fuerst, and B. Seale, Free gamma-aminobutyric acid in brain, J Biol Chem, vol.187, pp.35-44, 1950.

E. Bacon and F. Viennot, Le système complexe des récepteurs GABA-benzodiazépine. médecine/sciences, vol.6, p.770, 1990.

F. Balandras, J. Gaillard, F. Lauret, Y. Roux, . Le et al., Anxiolytic composition containing alpha-s1-casein-derived peptides, 2009.

F. Balandras, L. Miclo, J. Gaillard, Y. Roux, . Le et al., Casein-derived peptides having anxiolytic activity, 2008.

J. P. Balcombe, N. D. Barnard, and C. Sandusky, Laboratory routines cause animal stress, Contemp Top Lab Anim Sci, vol.43, pp.42-51, 2004.

D. M. Bannerman, R. Sprengel, D. J. Sanderson, S. B. Mchugh, J. Rawlins et al., Hippocampal synaptic plasticity, spatial memory and anxiety, Nat Rev Neurosci, vol.15, pp.181-92, 2014.

K. W. Barron, S. M. Pavelka, and K. M. Garrett, Diazepam-sensitive GABA(A) receptors in the NTS participate in cardiovascular control, Brain Res, vol.773, pp.53-60, 1997.

A. S. Basile, The Contribution of Endogenous Benzodiazepine Receptor Ligands to the Pathogenesis of Hepatic-Encephalopathy, Synapse, vol.7, pp.141-150, 1991.

A. M. Basso, K. B. Gallagher, J. P. Mikusa, and L. E. Rueter, Vogel conflict test: sex differences and pharmacological validation of the model, Behav Brain Res, vol.218, pp.174-83, 2011.

N. Bateson-a, Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal, Curr Pharm Des, vol.8, pp.5-21, 2002.

M. Bateson, Of (stressed) mice and men, Nat Methods, vol.11, pp.623-624, 2014.

C. Beata, E. Beaumont-graff, V. Coll, J. Cordel, M. Marion et al., Effect of alpha-casozepine (Zylkene) on anxiety in cats, J Vet Behav Clin Appl Res, vol.2, pp.40-46, 2007.

C. Beata, E. Beaumont-graff, C. Diaz, M. Marion, N. Massal et al., Effects of alpha-casozepine (Zylkene) versus selegiline hydrochloride (Selgian, Anipryl) on anxiety disorders in dogs, J Vet Behav Clin Appl Res, vol.2, pp.175-183, 2007.

C. H. Beck and H. C. Fibiger, Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment, J Neurosci, vol.15, pp.709-720, 1995.

C. Belzung and G. Griebel, Measuring normal and pathological anxiety-like behaviour in mice: A review, Behav Brain Res, vol.125, pp.141-149, 2001.

C. Belzung and M. Lemoine, Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression, Biol Mood Anxiety Disord, vol.1, p.9, 2011.
URL : https://hal.archives-ouvertes.fr/halshs-00792412

C. Belzung, G. Pape, and . Le, Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety, Physiol Behav, vol.56, pp.623-628, 1994.

S. Benoit, C. Chaumontet, J. Schwarz, C. Cakir-kiefer, D. Tomé et al., Mapping in mice the brain regions involved in the anxiolytic-like properties of a-casozepine , a tryptic peptide derived from bovine as1-casein, J Funct Foods, vol.38, pp.464-473, 2017.

D. Benton and R. T. Donohoe, The effects of nutrients on mood, Public Health Nutr, vol.2, pp.403-412, 1999.

D. Bentué-ferrer, M. Bureau, P. A. Allain, and H. , CNS Drug Rev, vol.2, pp.390-414, 1996.

P. Bercik, A. J. Park, D. Sinclair, A. Khoshdel, J. Lu et al., The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication, Neurogastroenterol Motil, vol.23, pp.1132-1141, 2011.

R. L. Berkowitz, J. D. Coplan, D. P. Reddy, and J. M. Gorman, The human dimension: how the prefrontal cortex modulates the subcortical fear response, Rev Neurosci, vol.18, pp.191-207, 2007.

Z. F. Bhat, S. Kumar, and H. F. Bhat, Bioactive peptides of animal origin: a review, J Food Sci Technol, 2015.

X. Bian, Physiological and morphological characterization of GABAergic neurons in the medial amygdala, Brain Res, vol.1509, pp.8-19, 2013.

G. Biggio, C. A. Corda, M. G. Giorgi, O. Sanna, E. Serra et al., GABAergic and dopaminergic transmission in the rat cerebral cortex: Effect of stress, anxiolytic and anxiogenic drugs, Pharmacol Ther, vol.48, pp.121-142, 1990.

S. Billioti-de-gage, Y. Moride, T. Ducruet, T. Kurth, H. Verdoux et al., , 2014.

, Benzodiazepine use and risk of Alzheimer's disease: case-control study, BMJ, vol.349, p.5205

D. C. Blanchard, R. J. Blanchard, P. Tom, and R. J. Rodgers, Diazepam changes risk assessment in an anxiety/defense test battery, Psychopharmacology (Berl), vol.101, pp.511-519, 1990.

D. C. Blanchard, G. Griebel, and R. J. Blanchard, Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic, Neurosci Biobehav Rev, vol.25, pp.205-223, 2001.

R. J. Blanchard and D. C. Blanchard, Bringing natural behaviors into the laboratory: a tribute to Paul MacLean, Physiol Behav, vol.79, pp.515-539, 2003.

R. J. Blanchard, G. Griebel, J. Henrie, and D. C. Blanchard, Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries, Neurosci Biobehav Rev, vol.21, pp.783-792, 1997.

A. L. Blas, . De, J. Vitorica, and P. Friedrich, Localization of the GABAA receptor in the rat brain with a monoclonal antibody to the 57,000 Mr peptide of the GABAA receptor/benzodiazepine receptor/Cl-channel complex, J Neurosci, vol.8, pp.602-616, 1988.

F. E. Bloom and L. L. Iversen, Localizing 3H-GABA in nerve terminals of rat cerebral cortex by electron microscopic autoradiography, Nature, vol.229, pp.628-658, 1971.

S. F. Boer, . De, and J. M. Koolhaas, Defensive burying in rodents: Ethology, neurobiology and psychopharmacology, Eur J Pharmacol, vol.463, pp.145-161, 2003.

M. Bogaert, . Van, L. Groenink, R. S. Oosting, K. Westphal et al., Mouse strain differences in autonomic responses to stress, Genes Brain Behav, vol.5, pp.139-188, 2006.

K. G. Borelli, C. Ferreira-netto, N. C. Coimbra, and M. L. Brandão, Fos-like immunoreactivity in the brain associated with freezing or escape induced by inhibition of either glutamic acid decarboxylase or GABAA receptors in the dorsal periaqueductal gray, Brain Res, vol.1051, pp.100-111, 2005.

D. Bouglé and S. Bouhallab, Dietary Bioactive Peptides: Human Studies, Crit Rev Food Sci Nutr, vol.8398, pp.0-00, 2015.

M. Bourin, Animal models for screening anxiolytic-like drugs: a perspective, Dialogues Clin Neurosci, vol.17, pp.295-303, 2015.

M. Bourin and M. Hascoët, The mouse light/dark box test, Eur J Pharmacol, vol.463, pp.55-65, 2003.

M. Bourin, B. Petit-demoulière, B. N. Dhonnchadha, and M. Hascöet, Animal models of anxiety in mice, Fundam Clin Pharmacol, vol.21, pp.567-74, 2007.

N. G. Bowery, Historical perspective and emergence of the GABAB receptor, Adv Pharmacol, vol.58, pp.1-18, 2010.

N. Bowery, A. Hudson, and G. Price, GABAA and GABAB receptor site distribution in the rat central nervous system, Neuroscience, vol.20, pp.365-83, 1987.

V. Brantl, H. Teschemacher, J. Bläsig, A. Henschen, and F. Lottspeich, Opioid activities of beta-casomorphins, Life Sci, vol.28, pp.1903-1912, 1981.

V. Brantl, H. Teschemacher, A. Henschen, and F. Lottspeich, Novel opioid peptides derived from casein (beta-casomorphins). I. Isolation from bovine casein peptone. Hoppe-Seyler's Zeitschrift fur, Ph siol Chemie, vol.360, pp.1211-1217, 1979.

J. A. Bravo, P. Forsythe, M. Chew, E. Escaravage, H. M. Savignac et al., , 2011.

, Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve, Proc Natl Acad Sci U S A, vol.108, pp.16050-16055

J. D. Bremner, M. Narayan, L. H. Staib, S. M. Southwick, T. Mcglashan et al., Neural correlates of memories of childhood sexual abuse in women with and without posttraumatic stress disorder, Am J Psychiatry, vol.156, pp.1787-95, 1999.

V. Brezinová and I. Oswald, Sleep after a bedtime beverage, Br Med J, vol.2, pp.431-434, 1972.

P. Briand, Avis de l'Agence française de sécurité sanitaire des aliments relatif à l'évaluation des allégations portant sur un hydrolysat trypsique de caséine bovine présenté en tant qu, 2007.

P. Broca, Sur la circonvolution limbique et la scissure limbique, Bull la Société d'anthropologie Paris, vol.12, pp.646-657, 1877.

S. E. Buffett-jerrott and S. H. Stewart, Cognitive and sedative effects of benzodiazepine use, Curr Pharm Des, vol.8, pp.45-58, 2002.

C. Cakir-kiefer, L. Miclo, F. Balandras, A. Dary, C. Soligot et al., Transport across Caco-2 cell monolayer and sensitivity to hydrolysis of two anxiolytic peptides from ?s1-casein, ?-casozepine, and ?s1-casein-f91-97: effect of bile salts, J Agric Food Chem, vol.59, pp.11956-65, 2011.

C. Cakir-kiefer, Y. Roux, . Le, F. Balandras, M. Trabalon et al., In vitro digestibility of ?-casozepine, a benzodiazepine-like peptide from bovine casein, and biological activity of its main proteolytic fragment, J Agric Food Chem, vol.59, pp.4464-72, 2011.

G. G. Calhoon and K. M. Tye, Resolving the neural circuits of anxiety, Nat Neurosci, vol.18, pp.1394-404, 2015.

A. C. Campos, M. Fogaça, D. C. Aguiar, and F. S. Guimarães, Animal models of anxiety disorders and stress, Rev Bras Psiquiatr, vol.35, pp.101-112, 2013.

M. Capogna, GABAergic cell type diversity in the basolateral amygdala, Curr Opin Neurobiol, vol.26, pp.110-116, 2014.

R. N. Cardinal, J. Parkinson, J. Hall, and B. J. Everitt, The contribution of the amygdala, nucleus accumbens, and prefrontal cortex to emotion and motivated behaviour, Int Congr Ser, vol.1250, pp.347-370, 2003.

W. A. Carlezon and M. J. Thomas, Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis, Neuropharmacology, vol.56, pp.122-154, 2009.

P. Carrive, The periaqueductal gray and defensive behavior: functional representation and neuronal organization, Behav Brain Res, vol.58, pp.27-47, 1993.

M. C. Carvalho, L. Albrechet-souza, S. Masson, and M. L. Brandão, Changes in the biogenic amine content of the prefrontal cortex, amygdala, dorsal hippocampus, and nucleus accumbens of rats submitted to single and repeated sessions of the elevated plus-maze test, 2005.

, médicas e biolo?icas / Soc Bras Biofi? ca, Brazilian J Med Biol Res = Rev Bras Pesqui, vol.38, pp.1857-66

M. C. Carvalho, C. M. Moreira, J. M. Zanoveli, and M. L. Brandao, Central, but not basolateral, amygdala involvement in the anxiolytic-like effects of midazolam in rats in the elevated plus maze, J Psychopharmacol, vol.26, pp.543-554, 2012.

R. C. Casper, Nutrients, neurodevelopment, and mood, Curr Psychiatry Rep, vol.6, pp.425-429, 2004.

K. J. Chang, P. Cuatrecasas, E. T. Wei, and J. K. Chang, Analgesic activity of intracerebroventricular administration of morphiceptin and beta-casomorphins: correlation with the morphine (micro) receptor binding affinity, Life Sci, vol.30, pp.1547-51, 1982.

K. J. Chang, A. Lillian, E. Hazum, P. Cuatrecasas, and J. K. Chang, Morphiceptin (NH4-tyr-prophe-pro-COHN2): a potent and specific agonist for morphine (mu) receptors, Science, vol.212, pp.75-82, 1981.

K. J. Chang, Y. F. Su, D. A. Brent, and J. K. Chang, Isolation of a specific mu-opiate receptor peptide, morphiceptin, from an enzymatic digest of milk proteins, J Biol Chem, vol.260, pp.9706-9718, 1985.

M. Chebib, GABAC receptor ion channels, Clin Exp Pharmacol Physiol, vol.31, pp.800-804, 2004.

H. Chiba, F. Tani, and M. Yoshikawa, Opioid antagonist peptides derived from kappa-casein, J Dairy Res, vol.56, pp.363-369, 1989.

L. Chung, A Brief Introduction to the Transduction of Neural Activity into Fos Signal, Dev Reprod, vol.19, pp.61-68, 2015.

C. Cohidon, Prévalence des troubles de santé mentale et conséquences sur l'activité professionnelle en France dans l'enquête " Santé mentale en population générale : images et réalités, 2007.

E. Costa and A. Guidotti, Molecular mechanisms in the receptor action of benzodiazepines, Annu Rev Pharmacol Toxicol, vol.19, pp.531-576, 1979.

R. F. Cox and M. A. Collins, The effects of benzodiazepines on human opioid receptor binding and function, Anesth Analg, vol.93, pp.354-362, 2001.

D. J. Craik, D. P. Fairlie, S. Liras, and D. Price, The future of peptide-based drugs, Chem Biol Drug Des, vol.81, pp.136-183, 2013.

J. N. Crawley, Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines, Pharmacol Biochem Behav, vol.15, pp.695-704, 1981.

J. N. Crawley, J. K. Belknap, A. Collins, J. C. Crabbe, W. Frankel et al., , 1997.

, Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies, Psychopharmacology (Berl), vol.132, pp.107-131

J. N. Crawley and L. G. Davis, Baseline exploratory activity predicts anxiolytic responsiveness to diazepam in five mouse strains, Brain Res Bull, vol.8, pp.609-621, 1982.

J. N. Crawley and F. K. Goodwin, Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines, Pharmacol Biochem Behav, vol.13, pp.167-70, 1980.

F. Crespi, Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety, J Neurosci Methods, vol.180, pp.97-105, 2009.

J. F. Cryan and F. F. Sweeney, The age of anxiety: Role of animal models of anxiolytic action in drug discovery, Br J Pharmacol, vol.164, pp.1129-1161, 2011.

M. G. Cunningham, C. M. Connor, . Carlezon-w-a, and E. Meloni, Amygdalar GABAergic-rich neural grafts attenuate anxiety-like behavior in rats, Behav Brain Res, vol.205, pp.146-153, 2009.

C. D'hulst, J. R. Atack, and R. F. Kooy, The complexity of the GABAA receptor shapes unique pharmacological profiles, Drug Discov Today, vol.14, pp.866-75, 2009.

T. Dalgleish, The emotional brain, Nat Rev Neurosci, vol.5, pp.583-589, 2004.

C. Dalla, K. Antoniou, G. Drossopoulou, M. Xagoraris, N. Kokras et al., , 2005.

, Chronic mild stress impact: are females more vulnerable?, Neuroscience, vol.135, pp.703-717

M. Davis, D. Rainnie, and M. Cassell, Neurotransmission in the rat amygdala related to fear and anxiety, Trends Neurosci, vol.17, pp.208-222, 1994.

G. Deacon, C. Kettle, D. Hayes, C. Dennis, and J. Tucci, Omega 3 polyunsaturated fatty acids and the treatment of depression, Crit Rev Food Sci Nutr, vol.57, pp.212-223, 2017.

D. Degrazia and . Rowan-a, Pain, suffering, and anxiety in animals and humans, Theor Med, vol.12, pp.193-211, 1991.

V. H. Denenberg, Open-field bheavior in the rat: what does it mean?, Ann N Y Acad Sci, vol.159, pp.852-859, 1969.

R. Dias, W. Sheppard, R. L. Fradley, E. M. Garrett, J. L. Stanley et al., Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines, J Neurosci, vol.25, pp.10682-10690, 2005.

G. Díaz-véliz, T. Alarcón, C. Espinoza, N. Dussaubat, and S. Mora, Ketanserin and anxiety levels: influence of gender, estrous cycle, ovariectomy and ovarian hormones in female rats, Pharmacol Biochem Behav, vol.58, pp.637-679, 1997.

. Dielenberg-r-a and I. S. Mcgregor, Defensive behavior in rats towards predatory odors: a review, Neurosci Biobehav Rev, vol.25, pp.597-609, 2001.

R. A. Dielenberg, P. Carrive, and I. S. Mcgregor, The cardiovascular and behavioral response to cat odor in rats: Unconditioned and conditioned effects, Brain Res, vol.897, pp.228-237, 2001.

R. A. Dielenberg, G. E. Hunt, and I. S. Mcgregor, When a rat smells a cat": The distribution of Fos immunoreactivity in rat brain following exposure to a predatory odor, Neuroscience, vol.104, pp.1085-1097, 2001.

C. I. Dixon, T. W. Rosahl, and D. N. Stephens, Targeted deletion of the GABRA2 gene encoding alpha2-subunits of GABA(A) receptors facilitates performance of a conditioned emotional response, and abolishes anxiolytic effects of benzodiazepines and barbiturates, Pharmacol Biochem Behav, vol.90, pp.1-8, 2008.

M. Dragunow and R. Faull, The use of c-fos as a metabolic marker in neuronal pathway tracing, J Neurosci Methods, vol.29, pp.261-266, 1989.

G. E. Duncan, D. J. Knapp, and G. R. Breese, Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety, Brain Res, vol.713, pp.79-91, 1996.

N. W. Dunham and T. S. Miya, A note on a simple apparatus for detecting neurological deficit in rats and mice, J Am Pharm Assoc Am Pharm Assoc (Baltim), vol.46, pp.208-217, 1957.

N. Egashira, M. Abe, A. Shirakawa, T. Niki, K. Mishima et al., Effects of mood stabilizers on marble-burying behavior in mice: involvement of GABAergic system, 2013.

, Psychopharmacology (Berl), vol.226, pp.295-305

S. J. Einöther and V. E. Martens, Acute effects of tea consumption on attention and mood, Am J Clin Nutr, vol.98, pp.1700-1708, 2013.

N. S. Endler and N. L. Kocovski, State and trait anxiety revisited, J Anxiety Disord, vol.15, pp.231-276, 2001.

A. Ermisch, H. J. Rühle, K. Neubert, B. Hartrodt, and R. Landgraf, On the blood-brain barrier to peptides: [3H]beta-casomorphin-5 uptake by eighteen brain regions in vivo, J Neurochem, vol.41, pp.1229-1262, 1983.

C. W. Erwin, M. Linnoila, J. Hartwell, A. Erwin, and S. Guthrie, Effects of buspirone and diazepam, alone and in combination with alcohol, on skilled performance and evoked potentials, J Clin Psychopharmacol, vol.6, pp.199-209, 1986.

W. K. Estes and B. F. Skinner, Some quantitative properties of anxiety, J Exp Psychol, vol.29, pp.390-400, 1941.

Z. Farzampour, R. J. Reimer, and J. Huguenard, Endozepines, Adv Pharmacol, vol.72, pp.147-64, 2015.

. Fda, New Dietary Ingredient Notification for Lactium, 1994.

S. E. File, The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs, J Neurosci Methods, vol.2, pp.219-257, 1980.

S. E. File, One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plusmaze, Psychopharmacology (Berl), vol.100, pp.281-283, 1990.

. Finn-d-a, M. T. Rutledge-gorman, and J. C. Crabbe, Genetic animal models of anxiety, Neurogenetics, vol.4, pp.109-144, 2003.

R. J. Fitzgerald and B. A. Murray, Bioactive peptides and lactic fermentations, Int J dairy Technol, vol.59, pp.118-125, 2006.

A. Fletcher, D. J. Bill, S. J. Bill, I. A. Cliffe, G. M. Dover et al., WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors, Eur J Pharmacol, vol.237, pp.283-91, 1993.

J. Foong and J. C. Bornstein, 5-HT antagonists NAN-190 and SB 269970 block alpha2-adrenoceptors in the guinea pig, Neuroreport, vol.20, pp.325-355, 2009.

K. Fosgerau and T. Hoffmann, Peptide therapeutics: current status and future directions, Drug Discov Today, vol.20, pp.122-130, 2015.

R. L. Fradley, M. R. Guscott, S. Bull, D. J. Hallett, S. C. Goodacre et al., , 2007.

, Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands, J Psychopharmacol, vol.21, pp.384-91

M. Fredrikson, G. Wik, P. Annas, K. Ericson, and S. Stone-elander, Functional neuroanatomy of visually elicited simple phobic fear: additional data and theoretical analysis, Psychophysiology, vol.32, pp.43-48, 1995.

M. P. Freeman, J. R. Hibbeln, K. L. Wisner, J. M. Davis, D. Mischoulon et al., Omega-Psychiatry, vol.67, pp.1954-67, 2006.

J. M. Fritschy and H. Mohler, GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits, J Comp Neurol, vol.359, pp.154-94, 1995.

J. Fujimura, M. Nagano, and H. Suzuki, Differential expression of GABA(A) receptor subunits in the distinct nuclei of the rat amygdala, Brain Res Mol Brain Res, vol.138, pp.17-23, 2005.

A. Gadek-michalska and J. Bugajski, Repeated handling, restraint, or chronic crowding impair the hypothalamic-pituitary-adrenocortical response to acute restraint stress, J Physiol Pharmacol, vol.54, pp.449-59, 2003.

A. Galeeva and P. Tuohimaa, Analysis of mouse plus-maze behavior modulated by ovarian steroids, Behav Brain Res, vol.119, pp.41-48, 2001.

C. R. Gardner, Distress vocalization in rat pups. A simple screening method for anxiolytic drugs, J Pharmacol Methods, vol.14, pp.181-188, 1985.

M. G. Gareau, M. A. Silva, and M. H. Perdue, Pathophysiological mechanisms of stress-induced intestinal damage, Curr Mol Med, vol.8, pp.274-81, 2008.

I. Geller and J. Seifter, The effects of mono-urethans, di-urethans and barbiturates on a punishment discrimination, J Pharmacol Exp Ther, vol.136, pp.284-292, 1962.

N. W. Gilpin, . Herman-m-a, and M. Roberto, The Central Amygdala as an Integrative Hub for Anxiety and Alcohol Use Disorders, Biol Psychiatry, vol.1, 2014.

R. A. Glennon, N. A. Naiman, M. E. Pierson, M. Titeler, R. A. Lyon et al., NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), Eur J Pharmacol, vol.154, pp.339-380, 1988.

F. Gómez-pinilla, Brain foods: the effects of nutrients on brain function, Nat Rev Neurosci, vol.9, pp.568-78, 2008.

E. B. Gordon, Letter: Tranquillizers causing aggression, Br Med J, vol.2, pp.36-43, 1975.

A. Gouveia, . Santos-ud-dos, F. E. Felisbino, T. L. Afonseca, . De et al., Influence of the estrous cycle on the behavior of rats in the elevated T-maze, Behav Processes, vol.67, pp.167-71, 2004.

J. Gray, The neuropsychology of anxiety: An inquiry into the functions of the septo-hippocampal system, Behav Brain Sci, 1982.

P. Graziani and . Colin, Anxiété et troubles anxieux, 2008.

G. Griebel, D. C. Blanchard, J. A. Lee, J. C. Masuda, C. K. Blanchard et al., Further evidence that the mouse defense test battery is useful for screening anxiolytic and panicolytic drugs: effects of acute and chronic treatment with alprazolam, Neuropharmacology, vol.34, pp.1625-1658, 1995.

G. Griebel and A. Holmes, 50 Years of Hurdles and Hope in Anxiolytic Drug Discovery, Nat Rev Drug Discov, vol.12, pp.667-87, 2013.

C. E. Griffin, A. M. Kaye, F. R. Bueno, and A. D. Kaye, Benzodiazepine pharmacology and central nervous system-mediated effects, Ochsner J, vol.13, pp.214-237, 2013.

C. T. Gross and N. S. Canteras, The many paths to fear, Nat Rev Neurosci, vol.13, pp.651-659, 2012.

B. Guesdon, M. Messaoudi, C. Lefranc-millot, G. Fromentin, D. Tomé et al., A tryptic hydrolysate from bovine milk alphaS1-casein improves sleep in rats subjected to chronic mild stress, Peptides, vol.27, pp.1476-82, 2006.

A. Guidotti, M. G. Corda, B. C. Wise, F. Vaccarino, and E. Costa, GABAergic synapses. Supramolecular organization and biochemical regulation, Neuropharmacology, vol.22, pp.1471-1479, 1983.

C. Hall and E. L. Ballachey, A study of the rat's behavior in a field. A contribution to method in comparative psychology, Univ Calif Publ Psychol, vol.6, pp.1-12, 1932.

S. L. Handley and S. Mithani, Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of "fear"-motivated behaviour, Naunyn Schmiedebergs Arch Pharmacol, vol.327, pp.1-5, 1984.

M. Hascoët and M. Bourin, A new approach to the light/dark test procedure in mice, Pharmacol Biochem Behav, vol.60, pp.645-53, 1998.

M. Hascoët, M. Bourin, and N. Dhonnchadha-b-a, The mouse light-dark paradigm: a review, Prog Neuropsychopharmacol Biol Psychiatry, vol.25, pp.141-66, 2001.

I. Hata, S. Higashiyama, and H. Otani, Identification of a phosphopeptide in bovine alpha s1-casein digest as a factor influencing proliferation and immunoglobulin production in lymphocyte cultures, J Dairy Res, vol.65, pp.569-78, 1998.

H. Autorité-de-santé, Affections psychiatriques de longue durée -Troubles anxieux graves, 2007.

A. Henschen, F. Lottspeich, V. Brantl, and H. Teschemacher, Novel opioid peptides derived from casein (beta-casomorphins). II. Structure of active components from bovine casein peptone. Hoppe-Seyler's Zeitschrift fur, Ph siol Chemie, vol.360, pp.1217-1241, 1979.

J. P. Herman, M. M. Ostrander, N. K. Mueller, and H. Figueiredo, Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis, Prog Neuropsychopharmacol Biol Psychiatry, vol.29, pp.1201-1214, 2005.

B. Hernández-ledesma, L. Amigo, M. Ramos, and I. Recio, Application of high-performance liquid chromatography-tandem mass spectrometry to the identification of biologically active peptides produced by milk fermentation and simulated gastrointestinal digestion, J Chromatogr A, vol.1049, pp.107-121, 2004.

B. Hernández-ledesma, M. J. García-nebot, S. Fernández-tomé, L. Amigo, and I. Recio, Dairy protein hydrolysates: Peptides for health benefits, Int Dairy J, vol.2, pp.18-27, 2013.

D. G. Herrera and H. A. Robertson, Activation of c-fos in the brain, Prog Neurobiol, vol.50, pp.83-107, 1996.

M. Hirsch, Avis de l'Agence française de sécurité sanitaire des aliments relatif à l'évaluation de l'allégation « contribue à réduire les effets du stress » d'un hydrolysat trypsique de caséine bovine présenté en tant qu, 2001.

M. Hirsch, Avis de l'Agence française de sécurité sanitaire des aliments relatif à l'évaluation de l'allégation « contribue à réduire les effets du stress » d'un hydrolysat trypsique de caséine bovine présenté en tant qu, 2002.

M. Hirsch, Avis de l'Agence française de sécurité sanitaire des aliments sur une demande d'évaluation de l'allégation « contribue à réduire les effets du stress » d'un hydrolysat trypsique de caséine bovine présenté en tant qu, 2003.

M. Hirsch, Avis de l'Agence française de sécurité sanitaire des aliments relatif à l'évaluation d'allégations portant sur un hydrolysat trypsique de caséine bovine présenté en tant qu, 2005.

G. E. Hoffman and D. Lyo, Anatomical Markers of Activity in Neuroendocrine Systems: Are we all "Fos-ed out, J Neuroendocrinol, vol.14, pp.259-268, 2002.

M. K. Hofmeijer-sevink, N. M. Batelaan, H. Megen, . Van, B. W. Penninx et al., Clinical relevance of comorbidity in anxiety disorders: a report from the Netherlands Study of Depression and Anxiety (NESDA), J Affect Disord, vol.137, pp.106-118, 2012.

R. C. Honey, A. Watt, and M. Good, Hippocampal lesions disrupt an associative mismatch process, J Neurosci, vol.18, pp.2226-2256, 1998.

M. B. Howren and J. Suls, The symptom perception hypothesis revised: depression and anxiety play different roles in concurrent and retrospective physical symptom reporting, J Pers Soc Psychol, vol.100, pp.182-95, 2011.

C. Hunt and C. Hambly, Faecal corticosterone concentrations indicate that separately housed male mice are not more stressed than group housed males, Physiol Behav, vol.87, pp.519-545, 2006.

J. L. Hurst and R. S. West, Taming anxiety in laboratory mice, Nat Methods, vol.7, pp.825-831, 2010.

A. T. Hussin, L. M. Fraser, A. Ramos, and R. E. Brown, The effect of chlordiazepoxide on measures of activity and anxiety in Swiss-Webster mice in the triple test, Neuropharmacology, vol.63, pp.883-892, 2012.

J. Hyttel, SCH 23390 -the first selective dopamine D-1 antagonist, Eur J Pharmacol, vol.91, pp.153-157, 1983.

S. Ikemoto and J. Panksepp, The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking, Brain Res Brain Res Rev, vol.31, pp.6-41, 1999.

A. Jacquet, A. Grolleau, J. Jove, R. Lassalle, and N. Moore, Burnout: evaluation of the efficacy and tolerability of TARGET 1® for professional fatigue syndrome (burnout), J Int Med Res, vol.43, pp.54-66, 2015.

. Johnston-g-a-r, Advantages of an antagonist: bicuculline and other GABA antagonists, Br J Pharmacol, vol.169, pp.328-364, 2013.

M. Julio-pieper, J. A. Bravo, E. Aliaga, and M. Gotteland, Review article: intestinal barrier dysfunction and central nervous system disorders--a controversial association, Aliment Pharmacol Ther, vol.40, pp.1187-201, 2014.

R. Kalisch, N. Salomé, S. Platzer, A. Wigger, M. Czisch et al., High trait anxiety and hyporeactivity to stress of the dorsomedial prefrontal cortex: a combined phMRI and Fos study in rats, Neuroimage, vol.23, pp.382-91, 2004.

A. Kalueff and D. J. Nutt, Role of GABA in anxiety and depression, Depress Anxiety, vol.24, pp.495-517, 2007.

N. Kanegawa, C. Suzuki, and K. Ohinata, Dipeptide Tyr-Leu (YL) exhibits anxiolytic-like activity after oral administration via activating serotonin 5-HT1A, dopamine D1 and GABAA receptors in mice, FEBS Lett, vol.584, pp.599-604, 2010.

S. F. Kash, L. H. Tecott, C. Hodge, and S. Baekkeskov, Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase, 1999.

, Proc Natl Acad Sci U S A, vol.96, pp.1698-703

W. A. Kaufmann, C. Humpel, G. F. Alheid, and J. Marksteiner, Compartmentation of alpha 1 and alpha 2 GABA(A) receptor subunits within rat extended amygdala: implications for benzodiazepine action, Brain Res, vol.964, pp.91-100, 2003.

J. Kim and J. Gorman, The psychobiology of anxiety, Clin Neurosci Res, vol.4, pp.335-347, 2005.

J. H. Kim, D. Desor, Y. T. Kim, W. J. Yoon, K. S. Kim et al., Efficacy of alphas1-casein hydrolysate on stress-related symptoms in women, Eur J Clin Nutr, vol.61, pp.536-577, 2007.

D. D. Kitts and K. Weiler, Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery, Curr Pharm Des, vol.9, pp.1309-1332, 2003.

M. Klarer, M. Arnold, L. Günther, C. Winter, W. Langhans et al., Gut vagal afferents differentially modulate innate anxiety and learned fear, J Neurosci, vol.34, pp.7067-76, 2014.

P. R. Kleinginna and A. M. Kleinginna, A categorized list of emotion definitions, with suggestions for a consensual definition, Motiv Emot, vol.5, pp.345-379, 1981.

H. Korhonen, Milk-derived bioactive peptides: From science to applications, J Funct Foods, vol.1, pp.177-187, 2009.

H. Korhonen and A. Pihlanto, Bioactive peptides: Production and functionality, Int Dairy J, vol.16, pp.945-960, 2006.

H. J. Korhonen, Production and properties of health-promoting proteins and peptides from bovine colostrum and milk, Cell Mol Biol, vol.59, pp.12-24, 2013.

K. J. Kovács, c-Fos as a transcription factor: a stressful (re)view from a functional map, Neurochem Int, vol.33, pp.287-97, 1998.

K. J. Kovács, Measurement of immediate-early gene activation-c-fos and beyond, J Neuroendocrinol, vol.20, pp.665-72, 2008.

M. Lader and D. Olajide, A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms, J Clin Psychopharmacol, vol.7, pp.11-16, 1987.

R. Lagnaoui, M. Tournier, Y. Moride, C. Wolfson, T. Ducruet et al., The risk of cognitive impairment in older community-dwelling women after benzodiazepine use, Age Ageing, vol.38, pp.226-234, 2009.

D. A. Laird and H. Drexel, Experimenting with food and sleep. I. Effects of varying types of foods in offsetting sleep disturbances caused by hunger pangs and gastric distress children and adults, J Am Diet Assoc, vol.10, pp.89-94, 1934.

R. Landgraf and A. Wigger, High vs low anxiety-related behavior rats: an animal model of extremes in trait anxiety, Behav Genet, vol.32, pp.301-315, 2002.

D. Lanoir, F. Canini, M. Messaoudi, C. Lefranc-millot, B. Demagny et al., Long term effects of a bovine milk alpha-s1 casein hydrolysate on healthy low and high stress responders, Stress, vol.5, p.124, 2002.

D. J. Laurie, W. Wisden, and P. H. Seeburg, The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development, J Neurosci, vol.12, pp.4151-4172, 1992.

A. Lecci, F. Borsini, A. Mancinelli, D. 'aranno, V. Stasi et al., Effect of serotoninergic drugs on stress-induced hyperthermia (SIH) in mice, J Neural Transm Gen Sect, vol.82, pp.219-249, 1990.

M. Lecouvey, C. Frochot, L. Miclo, P. Orlewski, A. Driou et al., Twodimensional 1H-NMR and CD structural analysis in a micellar medium of a bovine alphaS1-casein fragment having benzodiazepine-like properties, Eur J Biochem, vol.248, pp.872-880, 1997.

J. E. Ledoux, Emotion circuits in the brain, Annu Rev Neurosci, vol.23, pp.155-84, 2000.

J. E. Ledoux, The emotional brain, fear, and the amygdala, Cell Mol Neurobiol, vol.23, pp.727-765, 2003.

J. E. Ledoux, The amygdala, Curr Biol, vol.17, pp.868-874, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00634626

J. E. Ledoux, P. Cicchetti, . Xagoraris-a, and L. M. Romanski, The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning, J Neurosci, vol.10, pp.1062-1069, 1990.

S. Lee, S. Kim, O. Kwon, J. H. Lee, and J. Kim, Inhibitory networks of the amygdala for emotional memory, Front Neural Circuits, vol.7, p.129, 2013.

E. Leray, A. Camara, D. Drapier, F. Riou, N. Bougeant et al., Prevalence, characteristics and comorbidities of anxiety disorders in France: results from the "Mental Health in General Population" survey (MHGP), Eur Psychiatry, vol.26, pp.339-384, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01133893

G. Liebsch, . Montkowski-a, F. Holsboer, and R. Landgraf, Behavioural profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour, Behav Brain Res, vol.94, pp.301-311, 1998.

C. A. Lipinski, Lead-and drug-like compounds: The rule-of-five revolution, Drug Discov Today Technol, vol.1, pp.337-341, 2004.

C. A. Lipinski, Drug-like properties and the causes of poor solubility and poor permeability, J Pharmacol Toxicol Methods, vol.44, pp.235-284, 2004.

C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv Drug Deliv Rev, vol.46, pp.3-26, 2001.

R. G. Lister, Ethologically-based animal models of anxiety disorders, Pharmacol Ther, vol.46, pp.321-361, 1990.

X. Liu, R. Wu, F. Tai, L. Ma, B. Wei et al., Effects of group housing on stress induced emotional and neuroendocrine alterations, Brain Res, vol.1502, pp.71-80, 2013.

B. Lkhagvasuren, T. Oka, Y. Nakamura, H. Hayashi, N. Sudo et al., Distribution of Fos-immunoreactive cells in rat forebrain and midbrain following social defeat stress and diazepam treatment, Neuroscience, vol.272, pp.34-57, 2014.

F. Longordo, J. Fan, T. Steimer, C. Kopp, and A. Lüthi, A comparison of resting behavior, corticosterone levels and synaptic function in handled and undisturbed C57BL/6J mice, Sleep, vol.34, pp.679-81, 2011.

. Bibliography-xxxix,

F. Lottspeich, A. Henschen, V. Brantl, and H. Teschemacher, Novel opioid peptides derived from casein (beta-casomorphins). III. Synthetic peptides corresponding to components from bovine casein peptone. Hoppe-Seyler's Zeitschrift fur, Ph siol Chemie, vol.361, pp.1835-1844, 1980.

S. Loukas, D. Varoucha, C. Zioudrou, and . Streaty-r-a, Opioid activities and structures of alpha-casein-derived exorphins, Biochemistry, vol.22, pp.4567-73, 1983.

K. Löw, F. Crestani, R. Keist, D. Benke, I. Brünig et al., Molecular and neuronal substrate for the selective attenuation of anxiety, Science, vol.290, pp.131-135, 2000.

H. Lüddens, D. B. Pritchett, M. Köhler, I. Killisch, K. Keinänen et al., Cerebellar GABAA receptor selective for a behavioural alcohol antagonist, Nature, vol.346, pp.648-51, 1990.

P. D. Lukasiewicz, E. D. Eggers, B. T. Sagdullaev, and M. A. Mccall, GABAC receptor-mediated inhibition in the retina, Vision Res, vol.44, pp.3289-96, 2004.

R. L. Macdonald and R. W. Olsen, GABAA receptor channels, Annu Rev Neurosci, vol.17, pp.569-602, 1994.

P. D. Maclean, Psychosomatic disease and the visceral brain; recent developments bearing on the Papez theory of emotion, Psychosom Med, vol.11, pp.338-353, 1949.

P. D. Maclean, Some psychiatric implications of physiological studies on frontotemporal portion of limbic system (visceral brain), Electroencephalogr Clin Neurophysiol, vol.4, pp.407-418, 1952.

L. Mah, C. Szabuniewicz, and A. J. Fiocco, Can anxiety damage the brain?, Curr Opin Psychiatry, vol.29, pp.56-63, 2016.

T. Matsuda, P. Somboonthum, M. Suzuki, S. Asano, and A. Baba, Antidepressant-like effect by postsynaptic 5-HT1A receptor activation in mice, Eur J Pharmacol, vol.280, pp.235-243, 1995.

H. Matthies, H. Stark, B. Hartrodt, H. L. Ruethrich, H. T. Spieler et al., Derivatives of beta-casomorphins with high analgesic potency, Peptides, vol.5, pp.463-70, 1984.

S. M. Mcdonnell, J. Miller, and W. Vaala, Calming Benefit of Short-Term Alpha-Casozepine Supplementation During Acclimation to Domestic Environment and Basic Ground Training of Adult Semi-Feral Ponies, J Equine Vet Sci, vol.33, pp.101-106, 2013.

S. M. Mcdonnell, J. Miller, and W. Vaala, Modestly improved compliance and apparent comfort of horses with aversions to mildly-aversive routine healthcare procedures following short-term alpha-casozepine supplementation, J Equine Vet Sci, 2014.

R. M. Mckernan, T. W. Rosahl, D. S. Reynolds, C. Sur, . Wafford-k-a et al., Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype, Nat Neurosci, vol.3, pp.587-92, 2000.

R. M. Mckernan and P. J. Whiting, Which GABAA-receptor subtypes really occur in the brain?, Trends Neurosci, vol.19, pp.139-182, 1996.

P. Mcreynolds, Changing conceptions of anxiety: A historical review and a proposed integration, Issues Ment Health Nurs, vol.7, pp.131-158, 1985.

M. A. Medeiros, C. De, L. Reis, and E. Mello, Stress-induced c-Fos expression is differentially modulated by dexamethasone, diazepam and imipramine, Neuropsychopharmacology, vol.30, pp.1246-56, 2005.

J. H. Medina, C. Peña, M. Piva, A. C. Paladini, E. Robertis et al., Presence of benzodiazepinelike molecules in mammalian brain and milk, Biochem Biophys Res Commun, vol.152, pp.534-543, 1988.

H. Meisel and W. Bockelmann, Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties, Antonie Van Leeuwenhoek, vol.76, pp.207-222, 1999.

H. Meisel and H. Frister, Chemical characterization of bioactive peptides from in vivo digests of casein, J Dairy Res, vol.56, pp.343-352, 1989.

J. Merrer, . Le, B. Cagniard, and P. Cazala, Modulation of anxiety by mu-opioid receptors of the lateral septal region in mice, Pharmacol Biochem Behav, vol.83, pp.465-79, 2006.

M. Messaoudi, R. Lalonde, H. Schroeder, and D. Desor, Anxiolytic-like effects and safety profile of a tryptic hydrolysate from bovine alpha s1-casein in rats, Fundam Clin Pharmacol, vol.23, pp.323-353, 2009.

M. Messaoudi, C. Lefranc-millot, D. Desor, B. Demagny, and L. Bourdon, Effects of a tryptic hydrolysate from bovine milk alphaS1-casein on hemodynamic responses in healthy human volunteers facing successive mental and physical stress situations, Eur J Nutr, vol.44, pp.128-160, 2005.

L. Miclo, E. Perrin, A. Driou, V. Papadopoulos, N. Boujrad et al., , 2001.

, Characterization of alpha-casozepine, a tryptic peptide from bovine alpha(s1)-casein with benzodiazepine-like activity, FASEB J, vol.15, pp.1780-1782

M. P. Milagres, V. Minim, L. A. Minim, A. A. Simiqueli, L. Moraes et al., Night milking adds value to cow's milk, J Sci Food Agric, vol.94, pp.1688-92, 2014.

M. J. Millan, The neurobiology and control of anxious states, Prog Neurobiol, vol.70, pp.83-244, 2003.

M. Z. Mintzer, R. R. Griffiths, C. Contoreggi, A. S. Kimes, E. D. London et al., Effects of triazolam on brain activity during episodic memory encoding: a PET study, Neuropsychopharmacology, vol.25, pp.744-56, 2001.

M. Z. Mintzer, H. Kuwabara, M. Alexander, J. R. Brasic, W. Ye et al., Dose effects of triazolam on brain activity during episodic memory encoding: a PET study, 2006.

, Psychopharmacology (Berl), vol.188, pp.445-61

R. Misslin, C. Belzung, and E. Vogel, Behavioural validation of a light/dark choice procedure for testing anti-anxiety agents, Behav Processes, vol.18, pp.119-132, 1989.

T. Mizushige, N. Kanegawa, A. Yamada, A. Ota, R. Kanamoto et al., Aromatic amino acid-leucine dipeptides exhibit anxiolytic-like activity in young mice, Neurosci Lett, vol.543, pp.126-135, 2013.

T. Mizushige, Y. Sawashi, A. Yamada, R. Kanamoto, and K. Ohinata, Characterization of Tyr-Leu-Gly, a novel anxiolytic-like peptide released from bovine ?S-casein, FASEB J, vol.27, pp.2911-2918, 2013.

D. Mobbs, P. Petrovic, J. L. Marchant, D. Hassabis, N. Weiskopf et al., When fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts in humans, Science, vol.317, pp.1079-83, 2007.

D. P. Mohanty, S. Mohapatra, S. Misra, and P. S. Sahu, Milk derived bioactive peptides and their impact on human health-A REVIEW, Saudi J Biol Sci, 2015.

H. Möhler, The rise of a new GABA pharmacology, Neuropharmacology, vol.60, pp.1042-1051, 2011.

H. Möhler, The GABA system in anxiety and depression and its therapeutic potential, Neuropharmacology, vol.62, pp.42-53, 2012.

H. Möhler and T. Okada, Benzodiazepine receptor: demonstration in the central nervous system, Science, vol.198, pp.849-851, 1977.

N. P. Möller, K. E. Scholz-ahrens, N. Roos, and J. Schrezenmeir, Bioactive peptides and proteins from foods: indication for health effects, Eur J Nutr, vol.47, pp.171-82, 2008.

T. H. Moran, . Baldessarini-a-r, C. F. Salorio, T. Lowery, and G. J. Schwartz, Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin, Am J Physiol, vol.272, pp.1245-51, 1997.

C. M. Moreira, S. Masson, M. C. Carvalho, and M. L. Brandão, Exploratory behaviour of rats in the elevated plus-maze is differentially sensitive to inactivation of the basolateral and central amygdaloid nuclei, Brain Res Bull, vol.71, pp.466-74, 2007.

. Moreira-f-a, P. H. Gobira, T. G. Viana, H. Vicente-m-a,-zangrossi, and F. G. Graeff, Modeling panic disorder in rodents, Cell Tissue Res, vol.354, pp.119-144, 2013.

H. V. Morris, G. R. Dawson, D. S. Reynolds, J. R. Atack, and D. N. Stephens, Both alpha2 and alpha3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm, Eur J Neurosci, vol.23, pp.2495-504, 2006.

R. Nagpal, P. Behare, R. R. Kumar, A. Kumar, M. Arora et al., Bioactive peptides derived from milk proteins and their health beneficial potentials: an update, Food Funct, vol.2, pp.18-27, 2011.

A. Nehlig, Effects of coffee/caffeine on brain health and disease: What should I tell my patients?, Pract Neurol, vol.16, pp.89-95, 2016.

D. D. Nguyen, S. K. Johnson, F. Busetti, and V. A. Solah, Formation and Degradation of Betacasomorphins in Dairy Processing, Crit Rev Food Sci Nutr, vol.55, pp.1955-67, 2015.

P. T. Ninan, T. M. Insel, R. M. Cohen, J. M. Cook, P. Skolnick et al., Benzodiazepine receptor-mediated experimental "anxiety" in primates, Science, vol.218, pp.1332-1336, 1982.

&. Njung and S. L. Handley, Evaluation of marble-burying behavior as a model of anxiety, Pharmacol Biochem Behav, vol.38, pp.63-67, 1991.

A. B. Nongonierma and R. J. Fitzgerald, Bioactive properties of milk proteins in humans: A review, Peptides, vol.73, pp.20-34, 2015.

. Noni-i-de, R. J. Fitzgerald, H. Korhonen, Y. Roux, C. T. Le et al., Review of the potential health impact of ?-casomorphins, EFSA Sci Rep, vol.231, pp.1-107, 2009.

P. Nuss, Anxiety disorders and GABA neurotransmission : a disturbance of modulation, Neuropsychiatr Dis Treat, vol.165, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01233109

D. Nutt, GABAA receptors: subtypes, regional distribution, and function, J Clin Sleep Med, vol.2, pp.7-11, 2006.

D. Nutt, L. A. King, W. Saulsbury, and C. Blakemore, Development of a rational scale to assess the harm of drugs of potential misuse, Lancet, vol.369, pp.1047-53, 2007.

. O'brien-cp, Benzodiazepine use, abuse, and dependence, J Clin Psychiatry, vol.66, pp.28-33, 2005.

D. O'malley, J. , M. Gibney, S. M. Dinan, T. G. Cryan et al., Distinct alterations in colonic morphology and physiology in two rat models of enhanced stress-induced anxiety and depression-like behaviour, Stress, vol.13, pp.114-136, 2010.

J. Olivier, C. H. Vinkers, and B. Olivier, The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders, Front Pharmacol, vol.4, p.74, 2013.

R. W. Olsen, Analysis of ?-aminobutyric acid (GABA) type A receptor subtypes using isosteric and allosteric ligands, Neurochem Res, vol.39, pp.1924-1965, 2014.

R. W. Olsen, Allosteric Ligands and Their Binding Sites Define ?-Aminobutyric Acid (GABA) Type A Receptor Subtypes, Adv Pharmacol, vol.73, pp.167-202, 2015.

R. W. Olsen and W. Sieghart, International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function, Update. Pharmacol Rev, vol.60, pp.243-60, 2008.

R. W. Olsen and A. J. Tobin, Molecular biology of GABAA receptors, FASEB J, vol.4, pp.1469-80, 1990.

C. Ottley, Food and mood, Nurs Stand, vol.15, pp.46-52, 2016.

J. M. Palacios, J. K. Wamsley, and M. J. Kuhar, High affinity GABA receptors-autoradiographic localization, Brain Res, vol.222, pp.285-307, 1981.

P. Palanza, Animal models of anxiety and depression: how are females different?, Neurosci Biobehav Rev, vol.25, pp.219-233, 2001.

C. Palestrini, M. Minero, S. Cannas, G. Berteselli, E. Scaglia et al., Efficacy of a diet containing caseinate hydrolysate on signs of stress in dogs, J Vet Behav Clin Appl Res, vol.5, pp.309-317, 2010.

A. E. Panhelainen and E. R. Korpi, Evidence for a role of inhibition of orexinergic neurons in the anxiolytic and sedative effects of diazepam: A c-Fos study, Pharmacol Biochem Behav, vol.101, pp.115-139, 2012.

J. W. Papez, A proposed mechanism of emotion, J Neuropsychiatry Clin Neurosci, vol.7, pp.103-112, 1937.

Y. W. Park and M. S. Nam, Bioactive Peptides in Milk and Dairy Products: A Review, Korean J food Sci Anim Resour, vol.35, pp.831-871, 2015.

C. L. Parks, P. S. Robinson, E. Sibille, T. Shenk, and M. Toth, Increased anxiety of mice lacking the serotonin1A receptor, Proc Natl Acad Sci U S A, vol.95, pp.10734-10743, 1998.

G. Paxinos and K. Franklin, The Mouse Brain In Stereotaxic Coordinates, 2001.

A. Pélissolo, F. Maniere, B. Boutges, M. Allouche, C. Richard-berthe et al., Encephale, vol.33, pp.32-40, 2007.

C. Peña, J. H. Medina, M. Piva, L. E. Diaz, C. Danilowicz et al., Naturally occurring benzodiazepines in human milk, Biochem Biophys Res Commun, vol.175, pp.1042-50, 1991.

H. E. Peña, L. Peña, J. B. De, H. J. Kim, C. J. Botanas et al., Milk Collected at Night Induces Sedative and Anxiolytic-Like Effects and Augments Pentobarbital-Induced Sleeping Behavior in Mice, J Med Food, vol.18, pp.1255-61, 2015.

I. Peña, . Dela, H. J. Kim, L. Peña, J. B. De et al., A tryptic hydrolysate from bovine milk ?s1-casein enhances pentobarbital-induced sleep in mice via the GABAA receptor, Behav Brain Res, vol.313, pp.184-90, 2016.

S. J. Peroutka, 5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization, Trends Neurosci, vol.11, pp.496-500, 1988.

S. A. Perrine, B. A. Hoshaw, and E. M. Unterwald, Delta opioid receptor ligands modulate anxiety-like behaviors in the rat, Br J Pharmacol, vol.147, pp.864-72, 2006.

K. L. Phan, T. Wager, S. F. Taylor, and I. Liberzon, Functional neuroanatomy of emotion: a metaanalysis of emotion activation studies in PET and fMRI, Neuroimage, vol.16, pp.331-348, 2002.

J. P. Pinel and D. Treit, Burying as a defensive response in rats, J Comp Physiol Psychol, vol.92, pp.708-712, 1978.

A. Pitkänen, V. Savander, and J. E. Ledoux, Organization of intra-amygdaloid circuitries in the rat: An emerging framework for understanding functions of the amygdala, Trends Neurosci, vol.20, pp.517-523, 1997.

J. Podhorna, The experimental pharmacotherapy of benzodiazepine withdrawal, Curr Pharm Des, vol.8, pp.23-43, 2002.

A. M. Poulos, R. Ponnusamy, H. Dong, and M. S. Fanselow, Compensation in the neural circuitry of fear conditioning awakens learning circuits in the bed nuclei of the stria terminalis, Proc Natl Acad Sci U S A, vol.107, pp.14881-14887, 2010.

S. D. Primeaux, S. P. Wilson, A. J. Mcdonald, F. Mascagni, and M. Wilson, The role of delta opioid receptors in the anxiolytic actions of benzodiazepines, Pharmacol Biochem Behav, vol.85, pp.545-54, 2006.

D. B. Pritchett, H. Sontheimer, B. D. Shivers, S. Ymer, H. Kettenmann et al., Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology, Nature, vol.338, pp.582-587, 1989.

L. Prut and C. Belzung, The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review, Eur J Pharmacol, vol.463, pp.3-33, 2003.

R. Quirion and A. S. Weiss, Peptide E and other proenkephalin-derived peptides are potent kappa opiate receptor agonists, Peptides, vol.4, pp.445-454, 1983.

. R-core-team, R: A language and environment for statistical computing, 2013.

R. Radian, O. P. Ottersen, J. Storm-mathisen, M. Castel, and B. I. Kanner, Immunocytochemical localization of the GABA transporter in rat brain, J Neurosci, vol.10, pp.1319-1349, 1990.

A. Ramos, Animal models of anxiety: do I need multiple tests?, Trends Pharmacol Sci, vol.29, pp.493-498, 2008.

A. Ramos, E. Pereira, G. C. Martins, T. D. Wehrmeister, and G. S. Izídio, Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial, Behav Brain Res, vol.193, pp.277-288, 2008.

J. F. Randall-thompson, K. A. Pescatore, and E. M. Unterwald, A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors, Psychopharmacology (Berl), vol.212, pp.585-95, 2010.

W. S. Rasband, ImageJ, 1997.

S. L. Rauch, L. M. Shin, and C. I. Wright, Neuroimaging studies of amygdala function in anxiety disorders, Ann N Y Acad Sci, vol.985, pp.389-410, 2003.

P. Renaud and J. P. Blondin, The stress of Stroop performance: physiological and emotional responses to color-word interference, task pacing, and pacing speed, Int J Psychophysiol, vol.27, pp.87-97, 1997.

L. A. Riblet, A. S. Eison, M. S. Eison, D. P. Taylor, D. L. Temple et al., Neuropharmacology of buspirone, Psychopathology, vol.17, pp.69-78, 1984.

J. G. Richards and H. Möhler, Benzodiazepine receptors, Neuropharmacology, vol.23, pp.233-242, 1984.

M. B. Roberfroid, What is beneficial for health? The concept of functional food, Food Chem Toxicol, vol.37, pp.1039-1080, 1999.

R. J. Rodgers and J. K. Shepherd, Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice, Psychopharmacology (Berl), vol.113, pp.237-242, 1993.

U. Rudolph, F. Crestani, D. Benke, I. Brünig, . Benson-j-a et al., , 1999.

, Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes, Nature, vol.401, pp.796-800

U. Rudolph and F. Knoflach, Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes, Nat Rev Drug Discov, vol.10, pp.685-97, 2011.

U. Rudolph and H. Möhler, GABA-based therapeutic approaches: GABAA receptor subtype functions, Curr Opin Pharmacol, vol.6, pp.18-23, 2006.

N. Salomé, P. Salchner, O. Viltart, H. Sequeira, A. Wigger et al., , 2004.

, Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential Fos expression in HAB and LAB rats, Biol Psychiatry, vol.55, pp.715-738

J. J. Sandford, S. V. Argyropoulos, and D. J. Nutt, The psychobiology of anxiolytic drugs -Part 1: Basic neurobiology, Pharmacol Ther, vol.88, pp.197-212, 2000.

A. Savelli, L'anxiété et ses avatars ou de Freud à Freud, 2005.

P. Schoch, J. G. Richards, P. Häring, B. Takacs, C. Stähli et al., Co-localization of GABA receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies, Nature, vol.314, pp.168-71, 1985.

J. Schrezenmeir, H. Korhonen, C. Williams, H. S. Gill, and N. Shah, Foreword, Br J Nutr, vol.84, 2000.

T. Schunck, A. Mathis, G. Erb, I. J. Namer, A. Demazières et al., Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge, J Psychopharmacol, vol.24, pp.701-709, 2010.

W. F. Seidel, S. A. Cohen, N. G. Bliwise, and W. C. Dement, Buspirone: an anxiolytic without sedative effect, Psychopharmacology (Berl), vol.87, pp.371-374, 1985.

H. Selye, Stress and the General Adaptation Syndrome, Br Med J, vol.2, p.215, 1950.

N. Sestakova, A. Puzserova, M. Kluknavsky, and I. Bernatova, Determination of motor activity and anxiety-related behaviour in rodents: methodological aspects and role of nitric oxide, Interdiscip Toxicol, vol.6, pp.126-135, 2013.

D. Shash, T. Kurth, M. Bertrand, C. Dufouil, P. Barberger-gateau et al., , 2016.

, Benzodiazepine, psychotropic medication, and dementia: A population-based cohort study, Alzheimers Dement, vol.12, pp.604-617

D. Shaw, K. Norwood, and J. C. Leslie, Chlordiazepoxide and lavender oil alter unconditioned anxiety-induced c-fos expression in the rat brain, Behav Brain Res, vol.224, pp.1-7, 2011.

A. Shekhar, T. J. Sajdyk, D. R. Gehlert, and D. G. Rainnie, The amygdala, panic disorder, and cardiovascular responses, Ann N Y Acad Sci, vol.985, pp.308-333, 2003.

H. Shoji and K. Mizoguchi, Brain region-specific reduction in c-Fos expression associated with an anxiolytic effect of yokukansan in rats, J Ethnopharmacol, vol.149, pp.93-102, 2013.

W. Sieghart and G. Sperk, Subunit composition, distribution and function of GABA(A) receptor subtypes, Curr Top Med Chem, vol.2, pp.795-816, 2002.

A. J. Silva, J. H. Kogan, P. W. Frankland, and S. Kida, CREB and memory, Annu Rev Neurosci, vol.21, pp.127-175, 1998.

S. Silva and F. X. Malcata, Casein as source of bioactive peptides, Int Dairy J, vol.16, pp.945-960, 2005.

M. C. Silveira, G. Sandner, and F. G. Graeff, Induction of Fos immunoreactivity in the brain by exposure to the elevated plus-maze, Behav Brain Res, vol.56, pp.115-123, 1993.

N. Singewald, P. Salchner, and T. Sharp, Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs, Biol Psychiatry, vol.53, pp.275-83, 2003.

C. J. Siok, S. M. Cogan, L. B. Shifflett, A. C. Doran, B. Kocsis et al., Comparative analysis of the neurophysiological profile of group II metabotropic glutamate receptor activators and diazepam: effects on hippocampal and cortical EEG patterns in rats, Neuropharmacology, vol.62, pp.226-262, 2012.

A. Skórzewska, M. Lehner, A. Wis?owska-stanek, D. Turzy?ska, A. Sobolewska et al., GABAergic control of the activity of the central nucleus of the amygdala in low-and high-anxiety rats, Neuropharmacology, vol.99, pp.566-576, 2015.

K. S. Smith and U. Rudolph, Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes, Neuropharmacology, vol.62, pp.54-62, 2012.

K. Sokolowski and J. G. Corbin, Wired for behaviors: from development to function of innate limbic system circuitry, Front Mol Neurosci, vol.5, p.55, 2012.

B. L. Soldo, W. R. Proctor, and T. V. Dunwiddie, Ethanol differentially modulates GABAA receptor-mediated chloride currents in hippocampal, cortical, and septal neurons in rat brain slices, Synapse, vol.18, pp.94-103, 1994.

R. E. Sorge, L. J. Martin, K. A. Isbester, S. G. Sotocinal, S. Rosen et al., Olfactory exposure to males, including men, causes stress and related analgesia in rodents, Nat Methods, vol.11, pp.629-632, 2014.

A. Sousa-dp-de, . Soares-hocayen-p-de, L. N. Andrade, and R. Andreatini, A Systematic Review of the Anxiolytic-Like Effects of Essential Oils in Animal Models, Molecules, vol.20, pp.18620-60, 2015.

P. R. Southwell, C. R. Evans, and J. N. Hunt, Effect of a hot milk drink on movements during sleep, Br Med J, vol.2, pp.429-460, 1972.

C. D. Spielberger, Anxiety and behavior, 1966.

S. M. Stahl, Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder, J Clin Psychiatry, vol.63, pp.756-757, 2002.

T. Steimer, The biology of fear-and anxiety-related behaviors, Dialogues Clin Neurosci, vol.4, pp.231-280, 2002.

T. Steimer, Animal models of anxiety disorders in rats and mice: some conceptual issues, Dialogues Clin Neurosci, vol.13, pp.495-506, 2011.

M. Stein and T. Steckler, Behavioral neurobiology of anxiety and its treatment, 2010.

S. H. Stewart and H. A. Westra, Benzodiazepine side-effects: From the bench to the clinic, Curr Pharm Des, vol.8, pp.1-3, 2002.

A. Strauss-cv-de, M. A. Vicente, and H. Zangrossi, Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects, Behav Brain Res, vol.246, pp.103-113, 2013.

J. H. Sul, H. Kim, N. Huh, D. Lee, and M. W. Jung, Distinct roles of rodent orbitofrontal and medial prefrontal cortex in decision making, Neuron, vol.66, pp.449-60, 2010.

N. Sun and M. D. Cassell, Intrinsic GABAergic neurons in the rat central extended amygdala, J Comp Neurol, vol.330, pp.381-404, 1993.

Z. Sun, R. J. Cade, M. J. Fregly, M. Privette, and R. , Beta-casomorphin induces Fos-like immunoreactivity in discrete brain regions relevant to schizoprenia and autism, pp.67-83, 1999.

M. Suzuki, M. Nishina, S. Nakamura, and K. Maruyama, Benzodiazepine-sensitive GABA(A) receptors in the commissural subnucleus of the NTS are involved in the carotid chemoreceptor reflex in rats, Auton Neurosci, vol.110, pp.108-121, 2004.

J. Svedberg, J. Haas, . De, G. Leimenstoll, F. Paul et al., Demonstration of betacasomorphin immunoreactive materials in in vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans, Peptides, vol.6, pp.825-855, 1985.

K. R. Tan, M. Brown, G. Labouèbe, C. Yvon, C. Creton et al., Neural bases for addictive properties of benzodiazepines, Nature, vol.463, pp.769-774, 2010.

R. O. Tasan, . Bukovac-a, Y. N. Peterschmitt, S. B. Sartori, R. Landgraf et al., , 2011.

, Altered GABA transmission in a mouse model of increased trait anxiety, Neuroscience, vol.183, pp.71-80

B. L. Thompson and J. B. Rosen, Immediate-early gene expression in the central nucleus of the amygdala is not specific for anxiolytic or anxiogenic drugs, Neuropharmacology, vol.50, pp.57-68, 2006.

P. Tovote, J. P. Fadok, and A. Lüthi, Neuronal circuits for fear and anxiety, Nat Rev Neurosci, vol.16, pp.317-348, 2015.

D. Treit, J. P. Pinel, and H. C. Fibiger, Conditioned defensive burying: a new paradigm for the study of anxiolytic agents, Pharmacol Biochem Behav, vol.15, pp.619-645, 1981.

K. M. Tye, R. Prakash, S. Kim, L. E. Fenno, L. Grosenick et al., Amygdala circuitry mediating reversible and bidirectional control of anxiety, Nature, vol.471, pp.358-62, 2011.

S. Ueno, J. Bracamontes, C. Zorumski, D. S. Weiss, and J. H. Steinbach, Bicuculline and gabazine are allosteric inhibitors of channel opening of the GABAA receptor, J Neurosci, vol.17, pp.625-659, 1997.

M. Uusi-oukari and E. R. Korpi, Regulation of GABA(A) receptor subunit expression by pharmacological agents, Pharmacol Rev, vol.62, pp.97-135, 2010.

H. Uylings, H. J. Groenewegen, and B. Kolb, Do rats have a prefrontal cortex?, Behav Brain Res, vol.146, pp.3-17, 2003.

M. Valtonen, L. Niskanen, A. Kangas, and T. Koskinen, Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjects, Nord J Psychiatry, vol.59, pp.217-238, 2005.

I. Vetter, J. L. Davis, L. D. Rash, R. Anangi, M. Mobli et al., Venomics: A new paradigm for natural products-based drug discovery, Amino Acids, vol.40, pp.15-28, 2011.

A. N. Vgontzas, A. Kales, and E. O. Bixler, Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamics, Pharmacology, vol.51, pp.205-228, 1995.

N. Violle, M. Messaoudi, C. Lefranc-millot, D. Desor, A. Nejdi et al., , 2006.

, Ethological comparison of the effects of a bovine alpha s1-casein tryptic hydrolysate and diazepam on the behaviour of rats in two models of anxiety, Pharmacol Biochem Behav, vol.84, pp.517-540

P. Vlieghe, V. Lisowski, J. Martinez, and M. Khrestchatisky, Synthetic therapeutic peptides: science and market, Drug Discov Today, vol.15, pp.40-56, 2010.

J. R. Vogel, B. Beer, and D. E. Clody, A simple and reliable conflict procedure for testing antianxiety agents, Psychopharmacologia, vol.21, pp.1-7, 1971.

F. Vonderviszt, G. Mátrai, and I. Simon, Characteristic sequential residue environment of amino acids in proteins, Int J Pept Protein Res, vol.27, pp.483-92, 1986.

H. S. Wagner, B. Ahlstrom, J. P. Redden, Z. Vickers, and T. Mann, The myth of comfort food, Health Psychol, vol.33, pp.1552-1559, 2014.

D. L. Walker, D. J. Toufexis, and M. Davis, Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety, Eur J Pharmacol, vol.463, pp.199-216, 2003.

H. R. Wang, Y. S. Woo, and W. Bahk, Caffeine-induced psychiatric manifestations: a review, Int Clin Psychopharmacol, vol.30, pp.179-82, 2015.

A. Weinbroum, V. Rudick, P. Sorkine, Y. Nevo, P. Halpern et al., Use of flumazenil in the treatment of drug overdose: a double-blind and open clinical study in 110 patients, Crit Care Med, vol.24, pp.199-206, 1996.

G. Weniger, C. Lange, and E. Irle, Abnormal size of the amygdala predicts impaired emotional memory in major depressive disorder, J Affect Disord, vol.94, pp.219-229, 2006.

P. J. Whiting, GABA-A receptors: a viable target for novel anxiolytics?, Curr Opin Pharmacol, vol.6, pp.24-33, 2006.

M. A. Whittington, R. D. Traub, N. Kopell, B. Ermentrout, and E. H. Buhl, Inhibition-based rhythms: experimental and mathematical observations on network dynamics, Int J Psychophysiol, vol.38, pp.315-351, 2000.

G. Wik, M. Fredrikson, K. Ericson, L. Eriksson, S. Stone-elander et al., A functional cerebral response to frightening visual stimulation, Psychiatry Res, vol.50, pp.15-24, 1993.

M. A. Wilson, GABA physiology: modulation by benzodiazepines and hormones, Crit Rev Neurobiol, vol.10, pp.1-37, 1996.

R. C. Wilson, T. Vacek, D. L. Lanier, and D. Dewsbury, Open-field behavior in muroid rodents, Behav Biol, vol.17, pp.495-506, 1976.

W. Wisden, A. Herb, H. Wieland, K. Keinänen, H. Lüddens et al., Cloning, pharmacological characteristics and expression pattern of the rat GABAA receptor alpha, 1991.

C. Wolfman, C. Cunha, . Da, D. Jerusalinsky, L. De-stein et al., , 1991.

, Habituation and inhibitory avoidance training alter brain regional levels of benzodiazepine-like molecules and are affected by intracerebral flumazenil microinjection, Brain Res, vol.548, pp.74-80

, WHO Model List of Essential Medicines, World Health Organization, 2015.

M. A. Yassa, R. L. Hazlett, C. Stark, and R. Hoehn-saric, Functional MRI of the amygdala and bed nucleus of the stria terminalis during conditions of uncertainty in generalized anxiety disorder, J Psychiatr Res, vol.46, pp.1045-52, 2012.

Y. Yen, E. Anderzhanova, M. Bunck, J. Schuller, R. Landgraf et al., Cosegregation of hyperactivity, active coping styles, and cognitive dysfunction in mice selectively bred for low levels of anxiety, Front Behav Neurosci, vol.7, p.103, 2013.

M. Yoshikawa, Bioactive peptides derived from natural proteins with respect to diversity of their receptors and physiological effects, Peptides, vol.72, pp.1-18, 2015.

H. You, J. L. Kozuska, I. M. Paulsen, and S. Dunn, Benzodiazepine modulation of the rat GABAA receptor ?4?3?2L subtype expressed in Xenopus oocytes, Neuropharmacology, vol.59, pp.527-560, 2010.

A. B. Young and D. Chu, Distribution of GABAA, and GABAB, Receptors in Mammalian Brain : Potential Targets for Drug Development, Drug Dev Res, vol.21, pp.161-167, 1990.

S. Zangenehpour and A. Chaudhuri, Differential induction and decay curves of c-fos and zif268 revealed through dual activity maps, Brain Res Mol Brain Res, vol.109, pp.221-226, 2002.

D. R. Ziegler and J. P. Herman, Neurocircuitry of stress integration: anatomical pathways regulating the hypothalamo-pituitary-adrenocortical axis of the rat, Integr Comp Biol, vol.42, pp.541-51, 2002.

C. Zioudrou, R. A. Streaty, and K. Wa, Opioid peptides derived from food proteins. The exorphins, J Biol Chem, vol.254, pp.2446-2455, 1979.

, Treatment of benzodiazepine overdose with flumazenil. The Flumazenil in Benzodiazepine Intoxication Multicenter Study Group, Clin Ther, vol.14, pp.978-95

, Basic Neurochemistry: Molecular, Cellular, and Medical Aspects, 2006.

, Oxford Dictionary of English, 2010.